Pediatric patients with leukemia have longer stay if admitted on weekend
the ONA take:
According to a new study published in The Journal of the American Medical Association Pediatrics, pediatric patients with newly diagnosed leukemia who were admitted to the hospital on the weekend had a longer length of stay, a small delay in initiating chemotherapy, and a greater risk for respiratory failure; however, these patients did not have an increased risk for death.
Researchers analyzed data from the Pediatric Health Information System database from 1999 to 2011 and identified 10,720 pediatric patients with newly diagnosed acute lymphocytic leukemia (ALL) and acute myeloid leukemia (AML). Of those, 16.7% were admitted to the hospital on the weekend. Patients admitted on the weekend had a 1.4-day longer length of stay, a 0.36-day longer time to chemotherapy initiation, and an increased risk for respiratory failure.
Researchers suggest that hospitals should consider the need to admit pediatric patients with leukemia and the clinical resources available on the weekend, and determine whether available resources are allocated to those patients who require comprehensive care. A longer length of stay and an increased risk for respiratory failure increase the cost of admission and may increase the risk for readmission.
Weekend admission for pediatric patients with leukemia associated with a longer length of stay.
Leukemia is a common childhood cancer that accounts for about 30 percent of all pediatric cancer diagnoses. Previous research has indicated an increased risk of death in adults with leukemia whose first admission was on a weekend. But there has been little investigation of weekend admissions for pediatric leukemia patients.
- Cholesterol-Lowering Drugs May Prevent Breast Cancer Recurrence
- BBD Regimen Efficacious as First-line Therapy for Myeloma
- Idelalisib Increases Progression-Free Survival in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
- Some Early Breast Cancer Patients Should Have Breast Conservation Instead of Mastectomy
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- Decipher Genomic Classifier Prognostic for Distant Prostate Metastasis
- GUCS 2017: Adjuvant Trials in Post-radical Prostatectomy Prostate Cancer Feasible
- Annual Screening of High-Risk Smokers Only More Cost-effective Than Current Methods
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Metronomic Chemotherapy: Improved Tumor Blood Supply Leads to Better Treatment
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|